Table 9.
Risk factors for Os
| Factors | Univariate Cox Regression | Multivariate Cox Regression | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| P | HR | 95% CI | P | HR | 95% CI | |
| Gender | 0.341 | 0.589 | 0.198-1.753 | |||
| Age | 0.117 | 0.434 | 0.153-1.234 | |||
| T Stage | 0.951 | 0.965 | 0.307-3.030 | |||
| N Stage | 0.249 | 1.487 | 0.757-2.921 | |||
| Clinical Stage | 0.003 | 5.833 | 1.858-18.316 | 0.005 | 4.854 | 1.609-14.643 |
| Pathological Type | 0.946 | 1.015 | 0.662-1.557 | |||
| Scc-Ag | 0.407 | 1.283 | 0.712-2.314 | |||
| Cyfra21-1 | 0.733 | 0.934 | 0.633-1.379 | |||
| Treatment Plan | 0.328 | 0.587 | 0.203-1.704 | |||
Note: Squamous cell carcinoma-associated antigen (SCC-Ag), cytokeratin 19 fragment 21-1 (CYFRA21-1).